Literature DB >> 25907116

Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor.

Weijia Cheng1, Shiyou Chen, Ruiling Li, Yu Chen, Min Wang, Deyin Guo.   

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV) encodes eight accessory proteins, the functions of which are not yet fully understood. SARS-CoV protein 6 (P6) is one of the previously studied accessory proteins that have been documented to enhance viral replication and suppress host interferon (IFN) signaling pathways. Through yeast two-hybrid screening, we identified eight potential cellular P6-interacting proteins from a human spleen cDNA library. For further investigation, we targeted the IFN signaling pathway-mediating protein, N-Myc (and STAT) interactor (Nmi). Its interaction with P6 was confirmed within cells. The results showed that P6 can promote the ubiquitin-dependent proteosomal degradation of Nmi. This study revealed a new mechanism of SARS-CoV P6 in limiting the IFN signaling to promote SARS-CoV survival in host cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25907116      PMCID: PMC7091177          DOI: 10.1007/s12250-015-3581-8

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  30 in total

1.  Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication.

Authors:  Lindsay Lundberg; Chelsea Pinkham; Alan Baer; Moushimi Amaya; Aarthi Narayanan; Kylie M Wagstaff; David A Jans; Kylene Kehn-Hall
Journal:  Antiviral Res       Date:  2013-10-22       Impact factor: 5.970

2.  Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release.

Authors:  Wei Lu; Bo-Jian Zheng; Ke Xu; Wolfgang Schwarz; Lanying Du; Charlotte K L Wong; Jiadong Chen; Shuming Duan; Vincent Deubel; Bing Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

3.  Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.

Authors:  Martin Spiegel; Andreas Pichlmair; Luis Martínez-Sobrido; Jerome Cros; Adolfo García-Sastre; Otto Haller; Friedemann Weber
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Isolation and characterization of Nmi, a novel partner of Myc proteins.

Authors:  J Bao; A S Zervos
Journal:  Oncogene       Date:  1996-05-16       Impact factor: 9.867

5.  Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling.

Authors:  M Zhu; S John; M Berg; W J Leonard
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

6.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

7.  Severe acute respiratory syndrome coronavirus protein 6 is required for optimal replication.

Authors:  Jincun Zhao; Ana Falcón; Haixia Zhou; Jason Netland; Luis Enjuanes; Pilar Pérez Breña; Stanley Perlman
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

8.  Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane.

Authors:  Matthew Frieman; Boyd Yount; Mark Heise; Sarah A Kopecky-Bromberg; Peter Palese; Ralph S Baric
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

Review 9.  Severe acute respiratory syndrome in children.

Authors:  Gary W K Wong; Albert M Li; P C Ng; Tai F Fok
Journal:  Pediatr Pulmonol       Date:  2003-10

10.  Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

Authors:  Bart L Haagmans; Thijs Kuiken; Byron E Martina; Ron A M Fouchier; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Ton de Jong; Shigeyuki Itamura; Kwok-Hung Chan; Masato Tashiro; Albert D M E Osterhaus
Journal:  Nat Med       Date:  2004-02-22       Impact factor: 53.440

View more
  8 in total

1.  Porcine Epidemic Diarrhea Virus Infection Inhibits Interferon Signaling by Targeted Degradation of STAT1.

Authors:  Longjun Guo; Xiaolei Luo; Ren Li; Yunfei Xu; Jian Zhang; Jinying Ge; Zhigao Bu; Li Feng; Yue Wang
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

Review 2.  Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination.

Authors:  Hawley C Pruitt; Daniel J Devine; Rajeev S Samant
Journal:  Int J Cancer       Date:  2016-03-11       Impact factor: 7.396

Review 3.  The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses.

Authors:  Karl M Valerdi; Adam Hage; Sarah van Tol; Ricardo Rajsbaum; Maria I Giraldo
Journal:  Viruses       Date:  2021-02-26       Impact factor: 5.048

4.  Potential Molecular Mechanisms and Remdesivir Treatment for Acute Respiratory Syndrome Corona Virus 2 Infection/COVID 19 Through RNA Sequencing and Bioinformatics Analysis.

Authors:  G Prashanth; Basavaraj Vastrad; Chanabasayya Vastrad; Shivakumar Kotrashetti
Journal:  Bioinform Biol Insights       Date:  2021-12-23

5.  N-myc and STAT interactor is a novel biomarker of severity in community-acquired pneumonia: a prospective study.

Authors:  Wanying Zhang; Hui Zhou; Mengyuan Cen; Wei Ouyang; Jie Chen; Lexin Xia; Xiuhui Lin; Jinliang Liu; Teng He; Feng Xu
Journal:  Respir Res       Date:  2022-09-19

Review 6.  Functions of Coronavirus Accessory Proteins: Overview of the State of the Art.

Authors:  Puxian Fang; Liurong Fang; Huichang Zhang; Sijin Xia; Shaobo Xiao
Journal:  Viruses       Date:  2021-06-13       Impact factor: 5.048

7.  Human cytomegalovirus UL23 inhibits transcription of interferon-γ stimulated genes and blocks antiviral interferon-γ responses by interacting with human N-myc interactor protein.

Authors:  Linyuan Feng; Jingxue Sheng; Gia-Phong Vu; Yujun Liu; Chingman Foo; Songbin Wu; Phong Trang; Marco Paliza-Carre; Yanhong Ran; Xiaoping Yang; Xu Sun; Zemin Deng; Tianhong Zhou; Sangwei Lu; Hongjian Li; Fenyong Liu
Journal:  PLoS Pathog       Date:  2018-01-29       Impact factor: 6.823

Review 8.  COVID-19: Drug Targets and Potential Treatments.

Authors:  Carmen Gil; Tiziana Ginex; Inés Maestro; Vanesa Nozal; Lucía Barrado-Gil; Miguel Ángel Cuesta-Geijo; Jesús Urquiza; David Ramírez; Covadonga Alonso; Nuria E Campillo; Ana Martinez
Journal:  J Med Chem       Date:  2020-06-26       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.